Percutaneous repair of tricuspid regurgitation

Antonio Mangieri,Antonio Colombo

DOI: https://doi.org/10.1093/eurheartjsupp/suae018

2024-04-01

European Heart Journal Supplements

Abstract:Abstract Tricuspid regurgitation (TR) is common both in patients with left side valvular heart disease and in patients with permanent atrial fibrillation and is associated with increased mortality, morbidity, and an increased risk of hospitalization. Surgery for isolated tricuspid repair is a viable option but burdened by a high-operative risk and a post-operative course characterized by high morbidity. Recently, percutaneous interventional techniques have emerged as a viable option in selected high-risk patients who may clinically benefit from tricuspid valve repair. The purpose of this article is to provide an overview of the current state of transcatheter restorative treatment of TR by providing an overview of new devices in clinical development.

cardiac & cardiovascular systems

What problem does this paper attempt to address?

The paper primarily explores the issue of percutaneous repair of tricuspid regurgitation (TR). Tricuspid regurgitation is very common in patients with left-sided heart valve disease and permanent atrial fibrillation, and is associated with higher mortality, morbidity, and hospitalization risk. Although isolated tricuspid repair surgery is a viable option, its high surgical risk and postoperative complication rate make this method less than ideal.

In recent years, percutaneous interventional techniques have shown clinical benefits in certain high-risk patients as an alternative. This paper aims to outline the current state of transcatheter repair treatments for tricuspid regurgitation and introduce new devices in clinical development. Specifically:

1. **Current Status of Surgical Repair**: The most commonly used surgical repair technique is annuloplasty, which restores the original size of the valve annulus by placing an artificial ring through suturing. However, surgical repair carries certain risks and complications.

2. **Challenges of Percutaneous Repair**: Due to the anatomical characteristics of the tricuspid valve, the development of percutaneous repair techniques faces many challenges. For example, the proximity to the right coronary artery may increase the risk of iatrogenic injury; additionally, the highly dilated tricuspid annulus poses difficulties for device design.

3. **Existing Devices**: The main devices currently on the European market include TriClip, the PASCAL system, and Cardioband. These devices repair valve function through different mechanisms, such as TriClip reducing regurgitation by approximating the leaflets, while Cardioband reduces the annulus size by contracting the ring.

4. **Development of New Systems**: There are also some new systems under development that have not yet been approved, such as K-Clip, DragonFly, and DragonRing. These systems attempt to overcome the limitations of existing technologies through innovative designs.

In summary, this paper aims to evaluate the latest advancements and technical challenges in percutaneous repair of tricuspid regurgitation and provide guidance for future research directions.